{"id":39637,"date":"2025-12-11T08:35:44","date_gmt":"2025-12-11T08:35:44","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/tech-town-in-north-chinas-tianjin-fosters-emerging-powerhouses-in-biomedical-sector\/"},"modified":"2025-12-11T08:35:44","modified_gmt":"2025-12-11T08:35:44","slug":"tech-town-in-north-chinas-tianjin-fosters-emerging-powerhouses-in-biomedical-sector","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/tech-town-in-north-chinas-tianjin-fosters-emerging-powerhouses-in-biomedical-sector\/","title":{"rendered":"Tech Town in North China's Tianjin Fosters Emerging Powerhouses in Biomedical Sector"},"content":{"rendered":"
\n

TIANJIN, China, Dec. 11, 2025 (GLOBE NEWSWIRE) — Sino Bioking\u00a0(Tianjin) Biological Pharmaceutical Co., Ltd., a tech firm incubated in Beijing’s Zhongguancun, known as the country’s Silicon Valley, recently announced a major milestone: its recombinant feline interferon product\u00a0– classified as a Class II new veterinary drug\u00a0– is set to hit the market soon. This launch will fill a critical gap in China’s domestic veterinary drug landscape, marking a significant breakthrough for homegrown biopharmaceutical innovation.<\/p>\n

Beijing-Tianjin Zhongguancun Tech Town, located in Baodi District, Tianjin, is emerging as a vibrant hub for biomedical innovation, nurturing a new generation of high-potential enterprises amid the national strategy of Beijing-Tianjin-Hebei coordinated development.<\/p>\n

Attracted by the tech town’s strategic location and robust support policies, the Sino Bioking\u00a0selected the site for its manufacturing base upon recommendation from Beijing Zhongguancun. For Chen Huangshi, the company’s R&D-background general manager, the decision has proven transformative.<\/p>\n

During construction, the park’s “end-to-end dedicated\u00a0services”\u00a0streamlined the project timeline, while tailored approval processes and procedures under the “one enterprise, one specific policy”\u00a0framework enabled the company to achieve production readiness upon completion.<\/p>\n

Since relocating, the company\u00a0has undergone remarkable expansion: its R&D and quality control center expanded from 200 to 2,000 square meters, the R&D department moved to the tech city in 2023, and a third production line was completed and put into operation this year. The company has established two core technology platforms, creating an integrated one-stop R&D system covering gene discovery to formulation research, and accelerating the industrialization of new products.<\/p>\n

“Post-relocation, we have secured over 20 patents, with a range of pet pharmaceuticals pipeline for market launch. Our development has entered a fast track,”\u00a0noted Chen. Adding momentum, the company secured equity financing in March this year from a\u00a0financial service platform, a joint initiative of Beijing-Tianjin Zhongguancun Tech Town and Tianjin Science and Technology Innovation Angel Investment Co., Ltd., which further boosted its growth trajectory.<\/p>\n

Aligned with the Beijing-Tianjin-Hebei coordinated development strategy, Beijing-Tianjin Zhongguancun Tech Town has been pivotal in promoting technological innovation collaboration and industrial integration between Beijing and Tianjin. A string of major high-quality projects has settled in the park, driving initial industrial agglomeration effects and fostering a thriving ecosystem for biomedical startups.<\/p>\n

Wang Hao, deputy district mayor of Baodi District and Party secretary of Beijing-Tianjin Zhongguancun Tech Town, emphasized the park’s unique advantages: “Leveraging our Zhongguancun-like ecological system, the model of ‘R&D in Beijing-Tianjin, transformation in the region’\u00a0has matured significantly. Industries such as biomedicine are seeing enhanced technological intensity and unlocked development potential.”<\/p>\n

Looking ahead, Wang said the town will gather industries through talent, continue to cultivate this pilot field for Beijing-Tianjin-Hebei coordinated development, deepen benefit-sharing mechanisms, optimize the business environment, improve urban supporting facilities, and build a Beijing-Tianjin cooperation community with shared interests.<\/p>\n

As Beijing-Tianjin Zhongguancun Tech Town continues to refine its innovation ecosystem, it is poised to attract more biomedical enterprises, solidify its position as a key driver of regional industrial upgrading, and contribute to China’s broader biopharmaceutical innovation landscape.<\/p>\n

Source: Beijing-Tianjin Zhongguancun Tech Town<\/p>\n\n <\/div>\n","protected":false},"excerpt":{"rendered":"

TIANJIN, China, Dec. 11, 2025 (GLOBE NEWSWIRE) — Sino Bioking\u00a0(Tianjin) Biological Pharmaceutical Co., Ltd., a tech firm incubated in Beijing’s Zhongguancun, known as the country’s Silicon Valley, recently announced a major milestone: its recombinant feline interferon product\u00a0– classified as a Class II new veterinary drug\u00a0– is set to hit the market soon. This launch will […]<\/p>\n","protected":false},"author":2,"featured_media":39638,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/media\/NTRhNzNlMzUtODAxMC00NzczLWE4NjAtZGFmNTBiNDU5YzM5LTUwMDE1NTk5Ny0yMDI1LTEyLTExLWVu\/tiny\/Beijing-Tianjin-Zhongguancun-T.png","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-39637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t